验证数据展示
产品信息
17995-1-AP targets IL-29 in ELISA applications and shows reactivity with human samples.
| 经测试应用 | ELISA Application Description |
| 经测试反应性 | human |
| 免疫原 | IL-29 fusion protein Ag12444 种属同源性预测 |
| 宿主/亚型 | Rabbit / IgG |
| 抗体类别 | Polyclonal |
| 产品类型 | Antibody |
| 全称 | interleukin 29 (interferon, lambda 1) |
| 别名 | Cytokine Zcyto21, IFN lambda 1, IFNL1, IL 29, IL29, IL-29, Interferon lambda 1, Interleukin 29, ZCYTO21 |
| 计算分子量 | 200 aa, 22 kDa |
| GenBank蛋白编号 | BC074985 |
| 基因名称 | IL-29 |
| Gene ID (NCBI) | 282618 |
| 偶联类型 | Unconjugated |
| 形式 | Liquid |
| 纯化方式 | Antigen affinity purification |
| UNIPROT ID | Q8IU54 |
| 储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
| 储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Interleukin-29 (IL-29) is a member of the helical cytokine family and is a type III interferon. It is also known as IFNλ1 and is highly similar in amino acid sequence to the IL-28, the other type III interferon. It is produced predominantly by maturing dendritic cells and macrophages. It has been implicated in numerous immunological responses and has shown antiviral activity similar to the Type I interferons.Multiple studies also indicate IL-29's involvement in the pathogenesis of cancer, as well as its antitumor effects.